• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
Milwaukee Times Weekly Newspaper

Milwaukee Times Weekly Newspaper

Journalistic Excellence, Service, Integrity and Objectivity Always

July 11th, 2025
  • Home
  • Services
    • Advertising
  • News
    • Whats Happening?
    • Featured
    • Christian Times
      • Ministries List
    • Health
    • Education
    • Finance & Business
    • Lifestyles
      • Our History
    • Arts and Entertainment
    • Obituaries
  • Editorials
  • Contact Us
  • Digital Editions
  • Tweet
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email

Scientists gain genetic insight into Alzheimer’s disease

October 21, 2013

Study of mice builds on landmark findings from 1990s, researcher says

images

 

Researchers who identified two more gene mutations that increase a person’s risk of developing late-onset Alzheimer’s disease say their findings from studies with mice may help in efforts to prevent and treat the disease in humans.
The rare mutations occur in a gene called ADAM10 and are linked to the common form of Alzheimer’s that strikes after age 60. This is the second gene confirmed to play a role in late-onset Alzheimer’s and the fifth gene overall linked to the disease, according to the Massachusetts General Hospital researchers.
They found that the two mutations in ADAM10 increased production and accumulation of the beta-amyloid protein in the brains of mice. Beta-amyloid plaques are found in the brains of people with Alzheimer’s disease.
The mutations also reduce creation of new nerve-related cells in the hippocampus, a part of the brain essential to learning and memory.
The study appears in the October issue of the journal Neuron.
“This is the first report to document, in animal models, new [disease-causing] gene mutations for Alzheimer’s since the reports of the original four genes in the 1990s,” study senior author Rudolph Tanzi, director of the genetics and aging unit at the MassGeneral Institute for Neurodegenerative Disease, said in a hospital news release.
“What we found regarding the many effects of these two rare mutations in ADAM10 strongly suggests that diminished activity of this enzyme can cause [Alzheimer’s disease], and these findings support ADAM10 as a promising therapeutic target for both treatment and prevention,” he said.

  • Tweet
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email

Related Articles:

  • milwaukee-times-weekly-newspaper-logo-200px-tall
    Report: Alzheimer’s strikes women harder than men
  • Alzheimer’s disease: black Americans are hardest hit
    Alzheimer’s disease: black Americans are hardest hit
  • dr-cindy-carlsson
    Veteran's Association looking for participants in new Alzheimer's study
  • thinkstockphotos-89794447
    Why Alzheimer’s affects Blacks differently
  • DSC_7321
    Walgreens and Common Council team up to promote Alzheimer's awareness
  • Why are some women opting for total mastectomy as breast cancer prevention?
    Why are some women opting for total mastectomy as breast cancer prevention?

Filed Under: Health and Fitness

Primary Sidebar

Latest Issue PDF

Secondary Sidebar

Privacy Policy | Copyright © 2025 · HT Group, LLC. All Rights Reserved.